Cannabis and Arthritis: Osteoarthritis and RA Are Not the Same Question

Arthritis is among the most common reasons people try cannabis, and most discussion of it makes one mistake at the start: treating arthritis as a single condition.

Osteoarthritis is mechanical, involving cartilage breakdown and structural joint change, with inflammation as a secondary component. Rheumatoid arthritis is autoimmune, with the immune system attacking joint tissue and causing erosive damage that can be prevented by suppressing it.

That difference determines what cannabis can and cannot reasonably do.

Osteoarthritis: A Pain Management Question

In osteoarthritis the realistic goal is symptom relief. There is no established disease-modifying treatment for OA, so pain and function are what treatment targets, and cannabis competes with paracetamol, NSAIDs, exercise therapy, weight management and joint injections.

Evidence for cannabinoids specifically in OA is limited, and the broader chronic pain literature is more supportive. The 2017 National Academies review found substantial evidence that cannabis is effective for chronic pain in adults, which is the relevant general finding.

Animal work is more encouraging than human work. Studies in rat models of OA have reported that CBD reduced joint pain behaviour and nerve inflammation. That is a reasonable basis for interest and not a basis for confidence about people.

Rheumatoid Arthritis: The Part That Matters Most

Rheumatoid arthritis is where a mistaken framing becomes genuinely harmful.

RA causes progressive, irreversible joint erosion driven by autoimmune inflammation. Disease-modifying antirheumatic drugs, including methotrexate and biologics, prevent that damage. Early aggressive treatment substantially changes long-term joint outcomes, and delay causes deformity that cannot be undone.

Cannabis has not been shown to modify RA disease activity. A small trial of nabiximols in rheumatoid arthritis reported improvements in pain and sleep quality, which is symptom relief rather than disease control.

So the position is narrow and important: cannabis may help RA pain, and using it instead of DMARDs risks permanent joint destruction. Anyone tempted by that substitution because DMARD side effects are unpleasant should have that conversation with a rheumatologist, who has other options.

Topicals: Popular, Plausible, Undertested

Topical CBD creams and balms are the most common way people try cannabis for arthritis, and the reasoning is sound. Cannabinoid receptors exist in skin and peripheral tissue, application is localised, and there is no intoxication.

What is genuinely uncertain is whether enough cannabinoid crosses the skin to reach an affected joint. Cannabinoids are lipophilic and skin is an effective barrier. Formulation matters a great deal, and products vary enormously in how much they contain and whether they include permeation enhancers.

Practical guidance: superficial joints such as fingers, knees, wrists and elbows are more plausible targets than deep hips. Check the milligram content rather than a percentage, since many products contain very little. And expect that part of the benefit may come from massage and from menthol or camphor in the base.

The Arthritis Foundation has published guidance for adults with arthritis considering CBD, which reflects how common this is rather than a strong efficacy verdict.

What About Inflammation

Cannabinoids reduce inflammatory signalling in laboratory and animal work, largely through CB2 receptors on immune cells. Human evidence that cannabis reduces measurable inflammatory markers in arthritis is weak.

This mirrors the pattern in inflammatory bowel disease: symptom improvement without confirmed reduction in objective inflammation. Feeling better is worth having, and it is not the same as controlling disease.

Practical Guidance

Try topicals first for localised joint pain. Lowest risk, no intoxication, and reasonable for superficial joints.

For systemic use, start very low. Most arthritis patients are older, and older adults are more sensitive to THC.

Balanced or CBD-dominant products are usually the better starting point.

Keep taking DMARDs if you have RA. This is the single most important sentence here.

Check interactions. CBD inhibits cytochrome P450 enzymes, and methotrexate and other regimens need clinician review.

Do not abandon exercise and weight management in OA. Both have better evidence than anything else available.

Bottom Line

For osteoarthritis, cannabis is a reasonable thing to try for pain, with limited direct evidence and a supportive general chronic pain literature. For rheumatoid arthritis, it may help pain and does not control the disease, so it belongs alongside DMARDs rather than instead of them. Topicals are the sensible entry point for surface joints, with real uncertainty about how much gets through the skin.

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before making any health-related decisions.